Polyvascular disease raises heart attack and stroke risks. Atherosclerosis in multiple locations significantly increases odds of major coronary event, but aggressive treatment may help.
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000150:complications / Q000503:physiopathology*; D002318:Cardiovascular Diseases / Q000503:physiopathology*; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology / Q000503:physiopathology* / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D018570:Risk Assessment; D012307:Risk Factors; D020521:Stroke / Q000209:etiology / Q000503:physiopathology* / Q000517:prevention & control
D000924:Anticholesteremic Agents; D010975:Platelet Aggregation Inhibitors